RxDoctor Payments Data

Laurie Burnworth, PA

Medical · Queen Creek, AZNPI 1588904031

Payments from drug & device makers

$1,450in general payments, 2019–2025

Across 102 payments — averaging $14.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$503
  • AstraZeneca$160
  • Novo Nordisk$121
  • Vanda Pharmaceuticals Inc.$98
  • Boehringer Ingelheim$91
  • Amgen$81
  • plus $395 from 11 others

What the payments were for

  • Food & beverage$1,450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,450 in reported general payments places this provider in the 65th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Medicare billing

Part B allowed, 2024
$45,210
Medicare patients
223
Services billed
565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$40,918
JardianceEmpagliflozin21$33,118
Celecoxib28$3,158
Rosuvastatin Calcium79$1,600
Levothyroxine Sodium155$1,496
Atorvastatin Calcium160$1,385
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$1,128
Ezetimibe16$825
Gabapentin53$653
Omeprazole53$651
Albuterol Sulfate HfaAlbuterol Sulfate23$630
Losartan Potassium75$627
Amitriptyline Hcl11$590
Lisinopril91$573
Metformin Hcl75$489

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$121$40,91841 claims
Boehringer IngelheimJardiance$91$33,11821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 748 medical providers in Arizona.

Other medical in Queen Creek

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →